Association between insulin resistance and cholesteryl ester transfer protein gene polymorphism in type 2 diabetes mellitus

Chinese Journal of Medical Genetics

Volumn 22, Issue 3, 2005, Pages 298-301

  Jiang, Tao ^a   Song, Xiu Xia ^a   Zhang, Min ^a   Qi, Wei Hong ^b   Zhang, Xiao Wei ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b PEKING UNIVERSITY THIRD HOSPITAL   (China)

Author keywords

Cholesteryl ester transfer protein gene; Insulin resistance; Lipid metabolism; Type 2 diabetes

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHOSPHATIDYLCHOLINE STEROL ACYLTRANSFERASE; PHOSPHOLIPID TRANSFER PROTEIN; RESTRICTION ENDONUCLEASE; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION;

ADULT; AGED; AGED, 80 AND OVER; CHOLESTEROL ESTER TRANSFER PROTEINS; DIABETES MELLITUS, TYPE 2; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN RESISTANCE; LIPID METABOLISM; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 20644465188     PISSN: 10039406     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Tall AR. Plasma cholesteryl ester transfer protein and high-density lipoproteins: new insights from molecular genetic studies. J Intern Med, 1995, 237:5-12.
2. Ordovas JM. Genetic polymorphisms and activity of cholesteryl ester transfer protein(CETP): should we be measuring them? Clin Chem Lab Med, 2000, 38:945-949.
3. Haffner SM, Kennedy E, Gonzalez C, et al. A prospective analysis of the HOMA model. The Mexico City Diabetes Study. Diabetes Care, 1996, 19: 1138-1141.
4. Li GW, Pan XR, Lillioja S, et al. A new insulin sensitivity index for the population-based study. Chin J Int Med, 1993, 32:656-660.
5. Fumeron F, Betoulle D, Luc G, et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J Clin Invest, 1995, 96:1664-1671.
6. Ordovas JM, Cupples LA, Corella D, et al. Association of cholesteryl ester transfer protein TaqIB polymorphism with variations in lipoprotein subclasses and coronary heart disease risk: the framingham study. Arterioscler Thromb Vasc Biol, 2000, 20:1323-1329.
7. Liu J, Zhao D, Wu GX, et al. Study on the distribution and association of cholesteryl ester transfer protein-TaqIB gene polymorphism and plasma concentration in general Population. Chin J Epidemiol, 2003, 24:303-304.
8. Bernard S, Moulin P, Lagrost L, et al. Association between plasma HDL cholesterol concentration and TaqIB CETP gene polymorphism in non insulin dependent diabetes mellitus. J Lipid Res, 1998, 39:59-65.
9. Meguro S, Takei I, Murata M, et al. Cholesteryl ester transfer protein polymorphism associated with macroangiopathy in Japanese patients with type 2 diabetes. Atherosclerosis, 2001, 156:151-156.
10. Wu XH, Lu YS. Relationship between TaqIB CETP gene polymorphism and lipid metabolism in patients with type 2 diabetes. Chin J Med Lab Tech, 2003, 4:13-15.
11. Durlach A, Clavel C, Girard-Globa A, et al. Sex-dependent association of a genetic polymorphism of cholesteryl ester transfer protein with high-density lipoprotein cholesterol and macrovascular pathology in type II diabetic patients. J Clin Endocrinol Metab, 1999, 84:3656-3659.
12. Riemens SC, van Tol A, Stulp BK, et al. Influence of insulin sensitivity and the TaqIB cholesteryl ester transfer protein gene polymorphism on plasma lecithin: cholesterol acyltransferase and lipid transfer protein activities and their response to hyperinsulinemia in non-diabetic men. J Lipid Res, 1999, 40:1467-1474.
13. Kaser S, Foger B, Ebenbichler CF, et al. Influence of leptin and insulin on lipid transfer proteins in human hepatoma cell line, HepG2. Int J Obes Relat Metab Disord, 2001, 25:1633-1639.
14. Jonkers IJ, Smelt AH, Hattori H, et al. Decreased PLTP mass but elevated PLTP activity lined insulin resistance in HTG: effects of bezafibrate therapy. J Lipid Res, 2003, 44:1462-1469.